Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications
The summary for the Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD) invite the small business community to apply cutting edge technology to research to develop new approaches to prevent, treat, and cure type 1 diabetes and its complications. This RFA will utilize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) mechanisms, but will be run in parallel with other requests for applications (RFAs) of similar scientific scope (DK- 03-015 for Innovative Partners and DK-03-001 for Bench to Bedside) that will utilize the traditional research project grant (R01), the exploratory/developmental grant (R21) or the exploratory/developmental grant phase II (R33) grant mechanisms.
| Federal Grant Title: | Small Business Innovation Research (Sbir) and Small Business Technology Transfer (Sttr) to Develop New Therapies for Type 1 Diabetes and Its Complications |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Income Security and Social Services Health Education |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-DK-03-020 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.36193.837 |
| CFDA Descriptions: | Nursing Research 93.837 Heart and Vascular Diseases Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Feb 19, 2004 |
| Posted Date: | Aug 29, 2003 |
| Creation Date: | Mar 20, 2004 |
| Archive Date: | Mar 20, 2004 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.847 -- Diabetes, Endocrinology and Metabolism Research |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster